Retraction Note to: Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcino
- PDF / 119,472 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 5 Downloads / 136 Views
RETRACTION NOTE
Retraction Note to: Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma Luping Wang 1 & Junyu Wang 2 & Hong Zhao 2 & Guoping Jiang 1 & Xiaojie Feng 1 & Wenxia Sui 1 & Hongling Liu 1
# Springer-Verlag GmbH Germany, part of Springer Nature 2020
Retraction Note to: Naunyn-Schmiedeberg's Arch Pharmacol https://doi.org/10.1007/s00210-018-01607-w The Editor in Chief retracted this article (Wang et al. 2019) because of significant concerns regarding a number of Figures presented in this work, which question the integrity of the data. After publication, overlap was detected with figures in articles submitted and published within a close timeframe. Figure 1D contains images that appear to be the same or nearly the same as those in Fig. 1D of a different article ((Lin 2019), retracted) Figure 5F appears to contain two very similar images (case 1—low and case 2 – low) Figure 8D appears to be very similar to Fig. 3D in a different article ((Shen 2019), retracted) Figure 8E contains a number of images that appear to have been published previously in a number of unrelated publications, for instance (Liu and Yu 2018) (retracted), (Zou 2018; Du et al. 2019; Wang et al. 2018) Wang et al (2018) https:// doi.org/10.1016/j.pharep.2018.04.006. The authors were unable to provide raw data and stated that the figures were obtained through a commercial lab hired to perform some of the experiments for this study. The online version of the original article can be found at https://doi.org/ 10.1007/s00210-018-01607-w * Hongling Liu [email protected] 1
The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao 266071, Shandong, China
2
Qingdao Central Hospital, Qingdao, Shandong, China
Author Hongling Liu agreed to retraction but has not explicitly stated if they agree to this retraction notice. The remaining authors could not be contacted by the journal.
References Du Y et al (2019) Physcion 8-O-β-Glucopyranoside exerts anti-tumor activity against non-small cell lung Cancer by targeting PPARγ THE ANATOMICAL RECORD 302:785–793. https://doi.org/10. 1002/ar.23975 Retracted: Li et al (2019) Cytoprotective effects of euxanthone against ox-LDL-induced endothelial cell injury is mediated via Nrf2 Life Sciences V223, 174-184 https://doi.org/10.1016/j.lfs.2019.03.032 Retracted: Lin X et al (2019) FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis. Life Sciences V239, 117074. https://doi.org/10.1016/j.lfs.2019.117074 Retracted: Liu B and Yu S (2018) Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling. Biomedicine and Pahrmacotherapy V107, 243-253. https://doi.org/10.1016/j.biopha.2018.07.177 Retracted: Shen et al (2019) Amentoflavone Promotes Apoptosis in NonSmall-Cell Lung Cancer by Modulating Cancerous Inhibitor of PP2A Anat Rec Hoboken. __ V302, Issue 12, 2201-2210. https:// doi.org/10.1002/ar.24229 Wang M, Gao H, Qu H e
Data Loading...
